Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125881431 | 12588143 | 1 | I | 2008 | 20160627 | 20160725 | 20160725 | PER | US-PFIZER INC-2016320173 | PFIZER | 5.00 | DEC | F | Y | 0.00000 | 20160725 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125881431 | 12588143 | 1 | PS | VERAPAMIL HCL | VERAPAMIL HYDROCHLORIDE | 1 | Oral | 120 MG, 2X/DAY BY MOUTH; BLUE TABLET | Y | 18817 | 120 | MG | FILM-COATED TABLET | BID | |||||
| 125881431 | 12588143 | 2 | C | DEPO-PROVERA | MEDROXYPROGESTERONE ACETATE | 1 | 1 DF, CYCLIC; ONE INJECTION EVERY 3 MONTHS | 0 | 1 | DF | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125881431 | 12588143 | 1 | Heart rate irregular |
| 125881431 | 12588143 | 2 | Ovarian cyst |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125881431 | 12588143 | Gastric disorder | |
| 125881431 | 12588143 | Headache |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125881431 | 12588143 | 1 | 2008 | 2008 | 0 | |
| 125881431 | 12588143 | 2 | 1989 | 0 |